| JYSB2200076 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2022-04-24 | | Janssen Biologics BV;Cilag AG | | | view |
| JYSB2500021 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2025-02-05 | | Janssen Biologics BV | | | view |
| CYSB2200234 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(原2) | Supplementary Application | 2022-09-23 | | Hisun Biopharmaceutical Co Ltd | | | view |
| JYSB2300200 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2023-11-29 | | Janssen Biologics BV;Cilag AG | | | view |
| JYSB2200199 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2022-10-14 | | Janssen Biologics BV;Cilag AG | | | view |
| CYSB2400172 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(原2) | Supplementary Application | 2024-07-05 | | Hisun Biopharmaceutical Co Ltd | | | view |
| CYSB2300117 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(原2) | Supplementary Application | 2023-06-15 | | Taizhou Maibotaike Pharmaceutical Co Ltd | | | view |
| JYSB2400112 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2024-05-24 | | Janssen Biologics BV;Cilag AG | | | view |
| CYSB2300025 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(3.3) | Supplementary Application | 2023-02-01 | | Yuxi Genor Biotechnology Co Ltd | | | view |
| CYSB2200185 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(原2) | Supplementary Application | 2022-08-01 | | Taizhou Maibotaike Pharmaceutical Co Ltd | | | view |
| JYSB2200085 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2022-05-20 | | Janssen Biologics BV;Cilag AG | | | view |
| CYSB2400028 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2024-01-31 | | Taizhou Maibotaike Pharmaceutical Co Ltd | | | view |
| JXSS2100022 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(3.3) | Import Drug Application | 2021-04-02 | CELLTRION, Inc. | Celltrion Inc | In Review | 2021-04-02 | view |
| JXSS1000018 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Import Drug Application | 2010-11-04 | Centocor B.V. | Centocor BV;Cilag AG | Certificate Issued | 2013-08-22 | view |
| JXSL0700014 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(2) | Import Drug Application | 2007-05-11 | Centocor B.V. | Centocor BV | Certificate Issued | 2008-06-20 | view |
| JYSB2000342 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2020-07-08 | Janssen Biologics B.V. | Janssen Biologics BV;Cilag AG | Certificate Issued | 2020-09-17 | view |
| JYSB1700012 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2017-02-17 | Janssen Biologics B.V. | Janssen Biologics BV;Cilag AG | Certificate Issued | 2018-12-04 | view |
| JYSB2000149 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2020-05-09 | Janssen Biologics B.V. | Janssen Biologics BV;Cilag AG | In Review | 2020-05-08 | view |
| JYSB1900127 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2019-06-24 | Janssen Biologics B.V. | Janssen Biologics BV;Cilag AG | Certificate Issued | 2020-02-26 | view |
| JYSB1700005 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2017-01-22 | Janssen Biologics B.V. | Janssen Biologics BV;Cilag AG | Certificate Issued | 2017-05-25 | view |
